Nge Hoon S. et al, (2020), Journal of palliative care
OOMS A. et al, (2020)
A prospective study of diffusion-weighted magnetic resonance imaging for predicting outcome following chemoradiotherapy, in squamous cell carcinomas of the anus
Muirhead R. et al, (2019)
Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial.
Brims F. et al, (2019), Thorax, 74, 354 - 361
The Relationship of Quality of Life, Physical Symptoms and Survival in Mesothelioma - Exploratory Analyses from the Respect-Meso Study
Brims F. et al, (2019), American journal of respiratory and critical care medicine, 199
A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'
Brims F. et al, (2018), British journal of cancer, 119, 10 - 11
A phase I first-in-human, dose-escalation and expansion study to evaluate the safety and tolerability of NUC-3373 in patients with locally advanced, unresectable or metastatic solid malignancies.
Blagden S. et al, (2018), Ann oncol, 29 Suppl 8
Nutritional intervention and neurodevelopmental outcome in infants with suspected cerebral palsy: the Dolphin infant double-blind randomized controlled trial.
Andrew MJ. et al, (2018), Dev med child neurol, 60, 906 - 913
Corrigendum to "Heterologous Two-dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-lasting Cellular Immunity to Influenza Virus A in Healthy Adults" [EBioMedicine 29 (2018) 146-154].
Coughlan L. et al, (2018), Ebiomedicine, 31
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults.
Coughlan L. et al, (2018), Ebiomedicine, 29, 146 - 154